BioSpace News Archive

Business

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

July 8, 2024
·
8 min read
Drug Development

XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country

July 8, 2024
·
6 min read
Drug Development

Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC)

July 8, 2024
·
3 min read
Drug Development

AusperBio Highlights Major Advances in AHB-137 Clinical Development

July 8, 2024
·
3 min read
Drug Development

IDEAYA Announces Investor Webcast to Report Clinical Data Update for IDE397 Phase 2 Monotherapy Expansion Dose in MTAP-Deletion Urothelial and Lung Cancer on Monday, July 8, 2024

July 8, 2024
·
4 min read
Drug Development

AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19

July 8, 2024
·
4 min read
FDA

FDA Roundup: July 5, 2024

July 8, 2024
·
2 min read
Drug Development

IDEAYA Announces Positive Interim Phase 2 Monotherapy Expansion Data for IDE397 a Potential First-in-Class MAT2A Inhibitor in MTAP-Deletion Urothelial and Lung Cancer

July 8, 2024
·
9 min read
News

iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study

July 8, 2024
·
5 min read
Drug Development

TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor

July 8, 2024
·
15 min read